MedPath

The PRIDE Study Probiotics on Regulation and Improving Digestive hEalth

Phase 3
Completed
Conditions
Digestive Irregularity
Digestive Discomfort
History of Straining During Bowel Movements
History of Hard or Lumpy Stools
Interventions
Other: Probiotic strain of Bifidobacterium
Other: No Bifidobacterium
Registration Number
NCT01203462
Lead Sponsor
Georgetown University
Brief Summary

The purpose of this study is to determine the effect of probiotic supplemented yogurt in reducing colonic transit time (CTT) in females between the ages of 18-65 years old. Two yogurts will be administered, one containing a specific strain of probiotic in the Bifidobacterium genus and the other without the probiotic supplement. It is hypothesized that subjects receiving the probiotic supplemented yogurt will experience reduced CTT and improved gastrointestinal comfort and quality of life compared to those receiving the non-probiotic supplemented yogurt.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
68
Inclusion Criteria
  • Being female
  • Ability to speak and write English or Spanish
  • Willingness to refrain from specified probiotic supplements, during the 12 week trial (a list of prohibited products will be provided)
  • Have access to refrigeration and phone
  • Have a history of straining during bowel movements
  • Have a history of lumpy or hard stools
Exclusion Criteria
  • Presence of an allergy or intolerance to any ingredients in yogurt
  • Morbid obesity, defined as a BMI>40
  • Having inflammatory bowel disease
  • Having a history of malabsorption syndrome
  • Immunodeficiency, such as HIV or currently receiving chemotherapy
  • Consumption of any medications used to treat, prevent or cure diarrhea in the last month
  • Consumption of any medications used to treat, prevent or cure constipation in the last month
  • Diabetes mellitus
  • Thyroid disorders, including hypo- or hyperthyroidism
  • History of gastric, small bowel or colonic resection
  • Documented history of gastric emptying disorder
  • Consumption of narcotics, antipsychotic medications, or verapamil in the last month
  • Known pelvic outlet obstruction
  • Antibiotic usage within 4 weeks of enrollment
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Bifidobacterium supplemented yogurtProbiotic strain of BifidobacteriumBifidobacterium supplemented (minimum dosage of 1E+10cfu/serving) vanilla flavored yogurt containing starter cultures: Streptococcus thermophilus and Lactobacillus delbrueckii subsp. Bulgaricus
Placebo YogurtNo BifidobacteriumVanilla flavored yogurt containing starter cultures Streptococcus thermophilus and Lactobacillus delbrueckii subsp. Bulgaricus
Primary Outcome Measures
NameTimeMethod
Colonic Transit Time90 days
Secondary Outcome Measures
NameTimeMethod
Adverse events90 days
Frequency of bowel movements (daily)90 days
Stool consistency (daily)90 days
Well being as assessed by agreed upon quality of life instrument90 days
Dietary intake survey90 days
Tolerance90 days

by questionnaire: e.g. bloating

Rome criteria90 days
Bristol criteria90 days
Recovery of the probiotic in the faeces (quantitative measure)90 days
Bacterial composition of the fecal flora90 days

Trial Locations

Locations (1)

Georgetown University Department of Family Medicine, Research Division

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath